| [1] | 封敬颖, 边静, 崔毅轩, 等. 中空纤维离心超滤结合高效液相色谱法测定5-氟尿嘧啶的血药浓度[J]. 中国医院药学杂志, 2021, 41(13): 1305-1308. |
| [2] | 时静, 陈海生, 段存贤, 等. 5-氟尿嘧啶治疗药物监测的研究现状[J]. 中国临床药理学杂志, 2016, 32(11): 1053-1056. |
| [3] | LEE J J, BEUMER J H, CHU E. Therapeutic drug monitoring of 5-fluorouracil[J]. Cancer Chemotherapy and Pharmacology, 2016, 78(3): 447-464. doi: 10.1007/s00280-016-3054-2 |
| [4] | 何光照, 刘茜, 李小倩, 等. 氟尿嘧啶类药物个体化用药研究进展[J]. 中国医院药学杂志, 2018, 38(6): 679-683. |
| [5] | 范先煜, 汪硕闻, 范国荣. LC-MS/MS法同时检测人血浆中氟尿嘧啶、尿嘧啶和二氢尿嘧啶的浓度及其临床应用[J]. 药学服务与研究, 2021, 21(1): 12-18. |
| [6] | 曲恒燕, 郝光涛, 高洪志, 等. HPLC-MS/MS测定人血浆中5-氟尿嘧啶的浓度[J]. 药物分析杂志, 2013, 33(2): 259-262. |
| [7] | 佟志强, 吴东媛, 张娟, 等. UPLC-MS/MS法同时测定人血浆中5-FU及其代谢产物5-FUH2的浓度及应用[J]. 中国药房, 2021, 32(4): 480-484. |
| [8] | QIN W, WANG X X, CHEN W Q, et al. An invitro approach to simulate the process of 5-fluorouracil degradation with dihydropyrimidine dehydrogenase: The process in accordance to the first-order kinetic reaction[J]. Xenobiotica, 2021, 51(1): 24-30. doi: 10.1080/00498254.2020.1799451 |
| [9] | RADOVANOVIC M, SCHNEIDER J J, SHAFIEI M, et al. Measurement of 5- fluorouracil, capecitabine and its metabolite concentrations in blood using volumetric absorptive microsampling technology and LC-MS/MS[J]. Journal of Chromatography B, 2022, 1188: 123075. doi: 10.1016/j.jchromb.2021.123075 |
| [10] | LIU H Y, DING L, YU Y, et al. Comparison of three derivatization reagents for the simultaneous determination of highly hydrophilic pyrimidine antitumor agents in human plasma by LC-MS/MS[J]. Journal of Chromatography B, 2012, 893/894: 49-56. doi: 10.1016/j.jchromb.2012.02.033 |
| [11] | 鞠颖慧, 周琰, 彭颖斐, 等. 液相色谱串联质谱检测血浆5-氟尿嘧啶方法的建立及其临床应用[J]. 中华医学杂志, 2016, 96(10): 817-821. doi: 10.3760/cma.j.issn.0376-2491.2016.10.014 |